Published in PLoS Med on July 19, 2005
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest (2008) 2.12
Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. Clin Infect Dis (2010) 2.07
Grand challenges in global health: the ethical, social and cultural program. PLoS Med (2007) 2.02
We must not let protestors derail trials of pre-exposure prophylaxis for HIV. PLoS Med (2005) 1.68
Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLoS Med (2007) 1.68
Ethics and the ethnography of medical research in Africa. Soc Sci Med (2008) 1.57
Ethical challenges in the design and conduct of locally relevant international health research. Soc Sci Med (2007) 1.45
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early. BMJ (2005) 1.31
Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge. PLoS Med (2006) 1.29
Media reporting of tenofovir trials in Cambodia and Cameroon. BMC Int Health Hum Rights (2005) 1.15
Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access. J Int AIDS Soc (2015) 1.09
Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care STDS (2015) 0.99
'Who is Helsinki?' Sex workers advise improving communication for good participatory practice in clinical trials. Health Educ Res (2011) 0.97
The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community. PLoS Med (2005) 0.95
West African Bioethics Training Program: Raison D'être. Afr J Med Med Sci (2007) 0.94
Pre-exposure prophylaxis of HIV. Indian J Sex Transm Dis (2011) 0.94
The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention. J Int AIDS Soc (2015) 0.91
How ethical is your clinical trial? Int J Clin Pract (2010) 0.89
Getting personal: ethics and identity in global health research. Dev World Bioeth (2011) 0.87
Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States. Am J Law Med (2012) 0.85
Community engagement in biomedical research in an African setting: the Kintampo Health Research Centre experience. BMC Health Serv Res (2013) 0.83
Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand. PLoS One (2014) 0.82
"Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown. Am J Public Health (2011) 0.82
Addressing ethical, social, and cultural issues in global health research. PLoS Negl Trop Dis (2013) 0.81
Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study. PLoS One (2015) 0.81
Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials. J Empir Res Hum Res Ethics (2016) 0.79
Tracking the mutual shaping of the technical and social dimensions of solar-powered mosquito trapping systems (SMoTS) for malaria control on Rusinga Island, western Kenya. Parasit Vectors (2014) 0.78
Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention. Pharm Pract (Granada) (2009) 0.78
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. PLoS One (2011) 0.78
Pre-exposure prophylaxis of HIV: A right way to go or a long way to go? Artif Cells Nanomed Biotechnol (2014) 0.77
Assessing Clinical Research Capacity in Vietnam: A Framework for Strengthening Capability for Clinical Trials in Developing Countries. Public Health Rep (2016) 0.75
Legal and ethical values in the resolution of research-related disputes: how can IRBS respond to participant complaints? J Empir Res Hum Res Ethics (2014) 0.75
PrEP: controversy, agency and ownership. J Int AIDS Soc (2016) 0.75
PrEP Implementation Science: State-of-the-Art and Research Agenda. J Int AIDS Soc (2015) 0.75
Getting to zero the biomedical way in Africa: outcomes of deliberation at the 2013 Biomedical HIV Prevention Forum in Abuja, Nigeria. BMC Proc (2014) 0.75
Correlates of condom use among female sex workers in The Gambia: results of a cross-sectional survey. PeerJ (2015) 0.75
The Significance of Benefit Perceptions for the Ethics of HIV Research Involving Adolescents in Kenya. J Empir Res Hum Res Ethics (2017) 0.75
Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc (2009) 15.16
Trial of antiretroviral for HIV prevention on hold. Lancet Infect Dis (2004) 1.48
AIDS research. Cambodian leader throws novel prevention trial into limbo. Science (2004) 1.42
Standards of care in the antiretroviral rollout world. Lancet (2004) 1.39
Cambodia stops important tenofovir prevention trial. AIDS Treat News (2004) 1.34
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet (2010) 12.92
HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis (2010) 6.95
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS (2013) 3.17
Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev (2010) 3.08
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06
Does ratification of human-rights treaties have effects on population health? Lancet (2009) 2.93
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med (2008) 2.44
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet (2009) 2.35
History, principles, and practice of health and human rights. Lancet (2007) 2.19
Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08
The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One (2012) 2.05
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS (2012) 2.03
Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav (2012) 2.01
Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. BMJ (2009) 1.98
The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials (2009) 1.92
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health (2006) 1.91
Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS (2010) 1.88
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ (2012) 1.85
Neglected diseases, civil conflicts, and the right to health. Lancet (2007) 1.80
Iraq War mortality estimates: a systematic review. Confl Health (2008) 1.72
Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 1.66
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS (2011) 1.61
Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend (2007) 1.60
Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One (2011) 1.56
Sharing evidence on humanitarian relief. BMJ (2005) 1.56
Barriers to the effective treatment and prevention of malaria in Africa: A systematic review of qualitative studies. BMC Int Health Hum Rights (2009) 1.54
HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets (2011) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Safety of task-shifting for male medical circumcision: a systematic review and meta-analysis. AIDS (2012) 1.51
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis. AIDS (2013) 1.49
Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One (2011) 1.48
Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countries. Global Health (2011) 1.46
Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts. AIDS (2010) 1.41
Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS (2008) 1.35
Ethics of conducting research in conflict settings. Confl Health (2009) 1.34
HIV/AIDS in African militaries: an ecological analysis. Med Confl Surviv (2008) 1.34
Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens (2013) 1.33
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials (2009) 1.32
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis (2012) 1.30
The first decade of antiretroviral therapy in Africa. Global Health (2011) 1.27
In the era of systematic reviews, does the size of an individual trial still matter. PLoS Med (2008) 1.26
Aging with HIV in Africa: the challenges of living longer. AIDS (2012) 1.21
Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis (2010) 1.21
Disclosure of natural product use to primary care physicians: a cross-sectional survey of naturopathic clinic attendees. Mayo Clin Proc (2005) 1.20
Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol (2011) 1.18
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. AIDS (2011) 1.16
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials (2009) 1.15
The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther (2005) 1.11
Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis (2013) 1.11
Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. PLoS One (2011) 1.09
Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res (2009) 1.08
Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales. Nat Rev Rheumatol (2013) 1.07
Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution? BMC Med Res Methodol (2013) 1.06
Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials. PLoS One (2013) 1.05
Conflict and health: a paradigm shift in global health and human rights. Confl Health (2007) 1.04
Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries. AIDS (2012) 1.03
Do human rights matter to health? Lancet (2007) 1.03
Global health: the importance of evidence-based medicine. BMC Med (2013) 1.02
Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ (2012) 1.02
The effectiveness of anti-illicit-drug public-service announcements: a systematic review and meta-analysis. J Epidemiol Community Health (2011) 1.01
Water and sanitation infrastructure for health: The impact of foreign aid. Global Health (2010) 1.00
HIV and Africa's elderly: the problems and possibilities. AIDS (2012) 1.00
Simplified ART delivery models are needed for the next phase of scale up. PLoS Med (2011) 1.00
Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings. Ann Rheum Dis (2012) 1.00
Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts. PLoS One (2013) 0.99
Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One (2009) 0.98
Naturopathic treatment of rotator cuff tendinitis among Canadian postal workers: a randomized controlled trial. Arthritis Rheum (2009) 0.98
Changing attitudes towards polio vaccination: a randomized trial of an evidence-based presentation versus a presentation from a polio survivor. Vaccine (2005) 0.97
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis. Clin Infect Dis (2012) 0.97
Mobile phone text messages for improving adherence to antiretroviral therapy (ART): a protocol for an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 0.96
Can we increase male involvement in AIDS treatment? Lancet (2010) 0.96
Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy. Trop Med Int Health (2014) 0.95
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis. Ther Clin Risk Manag (2012) 0.95
Home-based HIV counseling and testing as a gateway to earlier initiation of antiretroviral therapy. Clin Infect Dis (2011) 0.94
Teaching evidence-based complementary and alternative medicine: 3. Asking the questions and identifying the information. J Altern Complement Med (2002) 0.94
Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment. Clin Epidemiol (2011) 0.93
Research into scorpion stings. BMJ (2011) 0.93
Simple, effective interventions are key to improving adherence in marginalized populations. Clin Infect Dis (2007) 0.93
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis. Clin Exp Gastroenterol (2012) 0.93
Sample size and power considerations in network meta-analysis. Syst Rev (2012) 0.91
Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallow. Antivir Ther (2013) 0.90
Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2). Trials (2009) 0.89
Lesotho embarks on universal HIV testing. HIV AIDS Policy Law Rev (2006) 0.89
Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Cephalalgia (2013) 0.89
Cost-effectiveness of naturopathic care for chronic low back pain. Altern Ther Health Med (2008) 0.89
Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. AIDS (2013) 0.89
Naturopathic care for chronic low back pain: a randomized trial. PLoS One (2007) 0.89
Therapeutic challenges in hepatitis C-infected injection drug using patients. Harm Reduct J (2006) 0.88
Statins for acute coronary syndrome. Cochrane Database Syst Rev (2014) 0.87
EDTA chelation therapy for cardiovascular disease: a systematic review. BMC Cardiovasc Disord (2005) 0.87
Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study. Patient Prefer Adherence (2013) 0.87
Introducing evidence-based complementary and alternative medicine: answering the challenge. J Altern Complement Med (2002) 0.87
Teaching evidence-based complementary and alternative medicine: 5. Interpreting the results of a study on therapy and applying them to a patient. J Altern Complement Med (2002) 0.86